Tissue Polypeptide-Specific Antigen (Tps) Immunoassay in the Diagnosis and Clinical Staging of Prostatic Carcinoma. Comparison with Prostate-Specific Antigen (Psa)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (20)
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 • 2,447 citations
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
1991 • 2,353 citations
Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
1991 • 1,273 citations
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated Patients
1989 • 877 citations
Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia
1990 • 625 citations
Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer
1989 • 511 citations
Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic Cancer
1987 • 313 citations
The Use of Prostate-Specific Antigen in Staging Patients With Newly Diagnosed Prostate Cancer
1993 • 291 citations
Immunoperoxidase localization of prostate-specific antigen
1982 • 106 citations
Multiple Immunoperoxidase Markers in Benign Hyperplasia and Adenocarcinoma of the Prostate
1984 • 90 citations
Distribution of tissue polypeptide antigen (TPA) in normal human tissues: Immunohistochemical study on unfixed, methanol-, ethanol-, and formalin-fixed tissues.
1985 • 85 citations
Pilot study of screening for prostate cancer in general practice
1991 • 60 citations
The Relationship of Prostate Specific Antigen Levels and Residual Tumor Volume in Stage a Prostate Cancer
1990 • 43 citations
Prostate Specific Antigen in Patients with Clinical Stage C Prostate Cancer: Relation to Lymph Node status and Grade
1991 • 37 citations
Prostate-specific antigen—comparative clinical appreciation of a serodiagnostic measure after 8 years of experience
1989 • 26 citations
Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
1993 • 19 citations
Tissue polypeptide-specific antigen: A discriminative parameter between prostate cancer and benign prostatic hypertrophy
1993 • 16 citations
Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.
1993 • 16 citations
Carcinoembryonic Antigen (CEA) and Tissue Polypeptide Antigen (TPA) in Normal and Neoplastic Human Tissues
1985 • 2 citations
Deleted Work
1955 • 0 citations